Cravath’s London Office Moves to 100 Cheapside
December 22, 2021
On December 1, 2021, Cravath partner John D. Buretta participated in the 38th annual “International Conference on the Foreign Corrupt Practices Act,” which was hosted by the American Conference Institute in Washington, D.C. from November 30 – December 3, 2021. John spoke on a panel entitled “AMLA and Anti‑Corruption: How the Application of AML Mechanisms to FCPA Prosecutions Affect Your Risk Calculus.” In addition to the recent enactment of the Anti‑Money Laundering Act of 2020, the panel discussed adjusted whistleblower rewards and protections, new and increased BSA penalties and their practical impact, the expanded authority to subpoena foreign financial institutions and preparing for increased prosecution of foreign nationals with limited ties to the U.S.
Deals & Cases
August 24, 2021
On August 24, 2021, Exyte Group (“Exyte”) and Wynnchurch Capital announced that they had reached an agreement for an all-share acquisition of Critical Process Systems Group, a group of manufacturing and design companies, by Exyte, a global leader in the design, engineering, and delivery of high-tech facilities. Cravath is representing Exyte in connection with the transaction.
Deals & Cases
August 17, 2021
On July 19, 2021, the U.S. Court of Appeals for the Second Circuit affirmed the district court’s dismissal of a second consolidated amended class action complaint alleging a violation of Section 1 of the Sherman Act as to Cravath client Nomura International plc and several other defendants.
Deals & Cases
July 30, 2021
On July 28, 2021, Swvl Inc. (“Swvl”), a Dubai‑based provider of transformative mass transit and shared mobility solutions, and Queen’s Gambit Growth Capital, the first special purpose acquisition company entirely led by women, announced that they have entered into a definitive agreement for a business combination that would result in Swvl becoming a publicly listed company. Upon completion of the proposed transaction, the combined public company will be named Swvl Holdings Corp and is expected to be the first $1 billion plus “unicorn” from the Middle East to list on NASDAQ, under the ticker symbol “SWVL”. Cravath is representing Swvl in connection with the transaction.
Deals & Cases
April 12, 2021
On April 11, 2021, DiaSorin S.p.A. (“DiaSorin”), a leading global diagnostics company, announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (“Luminex”), a leader in multiplexing technology, for a price of $37.00 per share in an all‑cash transaction corresponding to an enterprise value of approximately $1.8 billion. Cravath is representing DiaSorin in connection with the transaction.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.